Evidence map›Paper›PMID 35410237›Full record

ArticleJournal of experimental & clinical cancer research : CR2022

Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment.

Tzu-Chin Wu, Chien-Yu Liao, Wei-Chien Lu, Chuang-Rung Chang, Fang-Yu Tsai, Shih-Sheng Jiang, Tsung-Hsien Chen, Kurt Ming-Chao Lin, Li-Tzong Chen, Wun-Shaing Wayne Chang

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tzu-Chin Wu *National Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan.
Chien-Yu Liao *National Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan.
Wei-Chien LuNational Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan.
Chuang-Rung ChangInstitute of Molecular and Cellular Biology, College of Life Science, National Tsing Hua University, Hsinchu, 300044, Taiwan.
Fang-Yu TsaiNational Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan.
Shih-Sheng JiangNational Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan.
Tsung-Hsien ChenInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, 350401, Taiwan.
Kurt Ming-Chao LinInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, 350401, Taiwan.
Li-Tzong ChenNational Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan.
Wun-Shaing Wayne ChangNational Institute of Cancer Research, National Health Research Institutes, Zhunan, 350401, Taiwan. wayne@nhri.edu.tw.ORCID http://orcid.org/0000-0003-3098-6424
National Health Research Institutes · TWNational Tsing Hua University · TW

Funding

Ministry of Science and Technology, Taiwan 108-2314-B-400-025National Health Research Institutes, Taiwan CA-109-PP-15
6 · The paper itself

Abstract

backgroundPancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm with high metastatic potential and poor clinical outcome. Like other solid tumors, PDAC in the early stages is often asymptomatic, and grows very slowly under a distinct acidic pHe (extracellular pH) microenvironment. However, most previous studies have only reported the fate of cancerous cells upon cursory exposure to acidic pHe conditions. Little is known about how solid tumors-such as the lethal PDAC originating within the pancreatic duct-acinar system that secretes alkaline fluids-evolve to withstand and adapt to the prolonged acidotic microenvironmental stress.

methodsRepresentative PDAC cells were exposed to various biologically relevant periods of extracellular acidity. The time effects of acidic pHe stress were determined with respect to tumor cell proliferation, phenotypic regulation, autophagic control, metabolic plasticity, mitochondrial network dynamics, and metastatic potentials.

resultsUnlike previous short-term analyses, we found that the acidosis-mediated autophagy occurred mainly as an early stress response but not for later adaptation to microenvironmental acidification. Rather, PDAC cells use a distinct and lengthy process of reversible adaptive plasticity centered on the early fast and later slow mitochondrial network dynamics and metabolic adjustment. This regulates their acute responses and chronic adaptations to the acidic pHe microenvironment. A more malignant state with increased migratory and invasive potentials in long-term acidosis-adapted PDAC cells was obtained with key regulatory molecules being closely related to overall patient survival. Finally, the identification of 34 acidic pHe-related genes could be potential targets for the development of diagnosis and treatment against PDAC.

conclusionsOur study offers a novel mechanism of early rapid response and late reversible adaptation of PDAC cells to the stress of extracellular acidosis. The presence of this distinctive yet slow mode of machinery fills an important knowledge gap in how solid tumor cells sense, respond, reprogram, and ultimately adapt to the persistent microenvironmental acidification.

Indexed as

AcidosisCarcinoma, Pancreatic DuctalPancreatic NeoplasmsAdaptation, PhysiologicalCell Line, TumorGene Expression Regulation, NeoplasticHumansHydrogen-Ion ConcentrationPancreatic DuctsTumor MicroenvironmentAcidic stressAutophagyExtracellular pHFissionFusionMitochondrial dynamicsPancreatic ductal adenocarcinomaTumor microenvironment

Identifiers

PMID35410237
PMCPMC8996570
OpenAlexW4223448055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.